Fmoc-Lys(Mtt)-Wang resin (200-400 mesh, 0.5-0.8 mmol/g) |
|
Catalog No.GA21730
|
Fmoc-Lys(Mtt)-Wang resin (200-400 mesh, 0.5-0.8 mmol/g) is a polystyrene resin pre-loaded with Nα-Fmoc-Nε-(4-methyltrityl, Mtt)-L-lysine on a Wang (p-alkoxybenzyl alcohol/benzyl ester type linker) support, designed for Fmoc-based solid-phase peptide synthesis (SPPS).
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
Fmoc-Lys(Mtt)-Wang resin (200-400 mesh, 0.5-0.8 mmol/g) is a polystyrene resin pre-loaded with Nα-Fmoc-Nε-(4-methyltrityl, Mtt)-L-lysine on a Wang (p-alkoxybenzyl alcohol/benzyl ester type linker) support, designed for Fmoc-based solid-phase peptide synthesis (SPPS). Fmoc-Lys(Mtt)-Wang resin can be used for the preparation of linear/long-chain or difficult-sequence peptide acids, the construction of complex peptides requiring site-specific side-chain functionalization/branching/cyclization/labeling (e.g., biotin, fluorescent tags, PEG, etc.) at the lysine residue, as well as the synthesis of peptide drug intermediates and probes[1-4].
References:
[1] Josan JS, Morse DL, Xu L, et al. Solid-phase synthetic strategy and bioevaluation of a labeled delta-opioid receptor ligand Dmt-Tic-Lys for in vivo imaging. Org Lett. 2009 Jun 18;11(12):2479-82.
[2] Milićević D, Hlaváč J. Triple-FRET multi-purpose fluorescent probe for three-protease detection. RSC Adv. 2022 Oct 10;12(44):28780-28787.
[3] Aletras A, Barlos K, Gatos D, et al. Application in the synthesis of side-chain to side-chain cyclic peptides and oligolysine cores suitable for the solid-phase assembly of MAPs and TASPs. Int J Pept Protein Res. 1995 May;45(5):488-96.
[4] Al-Amri SM. Integrative Analysis of Metabolic Signature and Phytohormone Response in Potato Under Heat, Drought and Salt Stresses. Plants (Basel). 2026 Mar 9;15(5):844.
Synthesis of GGGKDex from Fmoc-Lys(Mtt)-Wang Resin[1]
This protocol is adapted from research data and provided for reference only. Adjustments may be necessary based on specific experimental requirements.
1. Resin initiation, swelling, and loading: Place the Fmoc-Lys(Mtt)-Wang resin into a solid-phase synthesis reaction vessel/reactor. Allow the resin to fully swell under infiltration conditions in N-methylpyrrolidone (NMP; containing 25% piperidine) or dichloromethane (containing 2% trifluoroacetic acid; TFA). Drain the solvent and set aside for subsequent steps.
2. Peptide chain elongation: Using 5 equiv of Fmoc-Gly-OH, 5 equiv of PyClock, and 10 equiv of DIEA in NMP, perform microwave-accelerated coupling on a microwave peptide synthesizer to sequentially graft Fmoc-Gly residues, yielding Fmoc-GGGK(Mtt)-resin (at this stage, the C-terminus is a Wang-ester-anchored lysine, with its ε-NH still protected by Mtt). Treat the resin with 25% piperidine in NMP, drain, and wash thoroughly with NMP followed by DCM before proceeding to the next coupling or operation. Repeat this procedure until the triglycine sequence GGG is fully assembled at the N-terminus of the peptide chain, obtaining Fmoc-GGGK(Mtt)-resin (N-terminus of the main chain: Fmoc-Gly-Gly-Gly-; side chain still: –NH-Mtt).
3. Selective Mtt deprotection and side-chain conjugation with SDex: Treat the Fmoc-GGGK(Mtt)-resin with 2% TFA in DCM and incubate for 20min to selectively remove the Mtt (4-methyltrityl) group from the lysine ε-position. Subsequently, continue washing the resin with 2% TFA in DCM until the Mtt is essentially completely removed. Mix the above resin with 2.5 equiv of SDex-COOH + 2.5 equiv of HATU + 2.5 equiv of HOAt + 5 equiv of DIEA + 5 equiv of 2,6-lutidine in 2.5mL of NMP. Place on an orbital shaker at room temperature overnight to complete the amidation labeling of SDex onto the side-chain ε-NH₂, yielding Fmoc-GGGKDex-resin. After the reaction, wash the resin thoroughly with NMP and DCM.
4. N-terminal final processing, resin cleavage, and product purification: Treat the Fmoc-GGGKDex-resin again with 25% piperidine in NMP to remove the N-terminal Fmoc group. Immerse the resin in cleavage cocktail (81.5% TFA / 5% thioanisole / 5% phenol / 5% H₂O / 2.5% ethanedithiol / 1% TIS) and incubate at 38°C for 30min, simultaneously cleaving the Wang-ester bond and removing all acid-labile side-chain protecting groups. Discharge/add the cleavage solution into 40mL of ice-cold diethyl ether to precipitate the crude peptide. After centrifugation/separation, resuspend the precipitate in water and lyophilize to obtain the crude peptide. Purify using a VYDAC C18 column (250mm × 10mm ID) with a linear gradient of acetonitrile/water (containing 0.1% TFA). Collect the target fraction and lyophilize to obtain the purified product GGGKDex.
Precautions:
(1) Mtt deprotection must be strictly controlled at a low TFA concentration.
(2) The 81.5% TFA final cleavage system contains highly corrosive TFA along with sulfur-containing/phenolic scavengers; operations must be performed in a fume hood with a face shield, acid-resistant gloves, and a lab coat. Keep the diethyl ether precipitation step away from open flames and heat sources. Organic waste containing TFA/aromatic fragments should be collected and disposed of separately as strong-acid halogenated organic waste.
(3) For your safety and health, please wear a lab coat and disposable gloves during operation.
References:
[1] Li M, Tao Y, Shu Y, et al. Discovery and characterization of a peptide that enhances endosomal escape of delivered proteins in vitro and in vivo. J Am Chem Soc. 2015 Nov 11;137(44):14084-93.
| Cas No. | SDF | ||
| Formula | M.Wt | ||
| Solubility | Soluble in DMSO | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 9 reference(s) in Google Scholar.)















